When adenovirus-mediated RNAi technology was used to knockdown the expression of Mcl-1 in GC, CD44+ cancer stem cell (CSC)-like cells became sensitized to chemotherapeutic agents such as 5-fluorouracil (5-FU) and cisplatin (CDDP) (95). The gene discussed is CD44; the disease is cancer.